SCOR Global Life SE now holds 98.67% of the capital of ReMark Group B.V. ("ReMark"), through a series of acquisitions dating from November 2006 when SCOR held 10.21%.
SCOR Global Life SE now holds 98.67% of the capital of ReMark Group B.V. ("ReMark"), through a series of acquisitions dating from November 2006 when SCOR held 10.21%.
SCOR Global Life SE now holds 98.67% of the capital of ReMark Group B.V. ("ReMark"), through a series of acquisitions dating from November 2006 when SCOR held 10.21%.
SCOR Global Life SE now holds 98.67% of the capital of ReMark Group B.V. ("ReMark"), through a series of acquisitions dating from November 2006 when SCOR held 10.21%.
SCOR's first half of 2007 results.
Strong growth of 55 % in SCOR SE First Half 2007 Turnover to EUR 2 124 Million.
Strong growth of 55 % in SCOR SE First Half 2007 Turnover to EUR 2 124 Million
SCOR Global Life's 2006 Embedded Value
SCOR Global Life European Embedded Value : EUR 1 513 million, up 10.8%.
SCOR Global Life European Embedded Value : EUR 1 513 million, up 10.8%
In the autumn of 2002, an international rugby football player was operated for a testicular tumour. He also underwent aggressive chemotherapy. In October 2003, he played in the Rugby World Cup in Australia.
In the autumn of 2002, an international rugby football player was operated for a testicular tumour. He also underwent aggressive chemotherapy. In October 2003, he played in the Rugby World Cup in Australia.
In the autumn of 2002, an international rugby football player was operated for a testicular tumour. He also underwent aggressive chemotherapy. In October 2003, he played in the Rugby World Cup in Australia.
Pagination